Prospective Assessment of TBDx Feasibility
NCT02912832 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 572
Last updated 2016-09-23
Summary
The purpose of this study will be to determine the performance characteristics of TBDx with culture as a gold standard. In addition, the investigators will assess the laboratory technicians' appraisal and technical suitability of the TBDx system.
Conditions
- Pulmonary Tuberculosis
Interventions
- DEVICE
-
TBDx
The TBDx is an automated platform is based on an Olympus BX41 microscope with a 40 x objective lens, fitted with an Olympus XC 10 colour camera and a movable slide stage, with an attached computer that receives high-quality digital images acquired from the camera. The computer then operates detection algorithms that segment, evaluate, and classify objects of interest in these images which can be stored for subsequent review. The platform is able to integrate an optional 200-slide automated slide loader for high volume settings. The application can capture 100, 300 or more digital fields-of-view and can provide results for positive or negative smears in 5 minutes or less.
Sponsors & Collaborators
-
Foundation for Innovative New Diagnostics, Switzerland
lead OTHER
Principal Investigators
-
Claudia M Denkinger, MD · Find
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-08-31
Countries
- Peru
- Vietnam
Study Locations
More Related Trials
-
Video-observed Therapy for Active Tuberculosis: a Feasibility Study
NCT06574529 ·Status: COMPLETED ·Phase: NA
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Plasma MTB cfDNA Before Bronchoscopy
NCT07230457 ·Status: NOT_YET_RECRUITING
-
PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
NCT07024836 ·Status: RECRUITING
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
Study of TB Lesions Obtained in Therapeutical Surgery
NCT02715271 ·Status: COMPLETED
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
NCT06845618 ·Status: RECRUITING
-
Using Biomarkers to Predict TB Treatment Duration
NCT02821832 ·Status: COMPLETED ·Phase: PHASE2
-
Research on New Regimens for Retreatment Pulmonary Tuberculosis
NCT02331823 ·Status: UNKNOWN ·Phase: PHASE4
-
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
NCT02512939 ·Status: COMPLETED ·Phase: NA
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA
-
Non-invasive TB Triage and Patient Mapping Platform Using Breath Via Low-Cost Titanium Dioxide Nanotube Sensor
NCT02681445 ·Status: COMPLETED
-
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
NCT00811343 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
NCT02231229 ·Status: COMPLETED ·Phase: PHASE4
-
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735 ·Status: RECRUITING
-
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
NCT04988984 ·Status: UNKNOWN
-
Comparison Between Two Strategies for the Diagnosis of TB
NCT02961569 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT06439810 ·Status: RECRUITING
-
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis
NCT06058299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN